Status:

COMPLETED

Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer

Lead Sponsor:

Capital Institute of Pediatrics, China

Conditions:

Pneumonia

Eligibility:

All Genders

28-18 years

Phase:

PHASE4

Brief Summary

Objective 1\. Master the clinical feathers, imaging features and laboratory diagnosis characteristics and economic costs of children pneumonia with higher D-dimer: 1. Compare the characteristics of ...

Detailed Description

This is a randomized, controlled, single blind trial(Researchers are not blind, patients are blind). 1.Patient population 1. .Experience group We will recruit 93 cases in our trial.All of them are w...

Eligibility Criteria

Inclusion

  • Clinical diagnosis of simple pneumonia
  • Age 28 days to 18 years

Exclusion

  • With congenital heart disease
  • With kidney disease
  • With blood system diseases
  • With paralysis
  • With muscle tension
  • With fracture,
  • With a family history of thrombotic disease
  • With indwelling central venous catheters
  • With parenteral nutrition, neoplastic disease
  • With primary immunodeficiency disease

Key Trial Info

Start Date :

December 1 2014

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2018

Estimated Enrollment :

124 Patients enrolled

Trial Details

Trial ID

NCT04778917

Start Date

December 1 2014

End Date

February 1 2018

Last Update

March 3 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Capital Institute of Pediatrics

Beijing, China

Observation and Treatment of Pulmonary Microthrombosis in Childhood Pneumonia With Elevated D-dimer | DecenTrialz